Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | Biopharm Knowledge Publishing | Outlook 2009 - Global Pharmaceutical and Biotechnology Markets

Outlook 2009 - Global Pharmaceutical and Biotechnology Markets

In the last decade the pharmaceutical market has changed completely. In 2000 the average PE ratio for companies in the pharmaceutical and biotech sector was more than 30, now that ratio has come down to just 14. Part of that change is due to the world economy, but it is also due to the performance of the pharma sector. The old blockbuster model no longer works and many major companies have struggled to come to terms with the new ways of working that are now needed for success – they are performing poorly and growth is slowing. But there are companies primed for success, and this report shows you which they are and why.

This unique report makes sense of a rapidly changing pharmaceutical market and provides unparalleled insight and analysis that will enable you to seek out the capabilities that are needed for success and the companies that have those capabilities.

Based on extensive research and data analysis by Mehta Partners the report looks beyond the usual limited range of companies. There are sections on Rising Stars – companies that are currently making losses – on Indian Generic companies and on the key players in Japan.

In all the 500+ page report looks at six market sections:

* Rising Stars

* Mature Biotech

* Indian Generics

* Global Pharma

* Japan – Global and Emerging

* Specialty Pharma

For each market place the report provides a detailed sector overview and then recommends the companies that will succeed and explains why.

Each company analysis includes a detailed drug-by-drug pipeline analysis with explanations of how a drug will perform in its therapy area and why. And there is an in-depth look at the current portfolio with generic exposure analysis and sales projections to 2013.

The presentation below will give you a good idea of the type of highly-detailed information that is contained in the report and we would be very happy to give you a full demonstration over the web or face to face – just call 01300 321501 to arrange a demonstration.

January 2009
Powerpoint Presentation
Price: $14,000.00 / €9,357.60

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions